Real-time imaging during brain tumor surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project investigates the use of the CONVIVO system, a handheld imaging technology that provides real-time digital images of tissue microstructure during neurosurgery. The goal is to improve the surgical treatment of brain tumors by allowing surgeons to distinguish between healthy and abnormal tissues more effectively. By enabling intraoperative visualization at cellular resolution, this method aims to optimize biopsy procedures and enhance the accuracy of tumor resections. The study will involve 30 patients diagnosed with intrinsic brain tumors to assess the ease of use and effectiveness of this technology.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* . The patient is suffering from an intracranial lesion requiring surgery:
* Patients undergoing neurosurgical resection for intrinsic presumably high grade, invasive tumors.
* Patients undergoing neurosurgical resection for other brain tumors,.
* All patient groups will only be comprised of elective surgical patients who have signed the informed consent prior to use

Exclusion Criteria:

* History of hypersensitivity to fluorescein
* History of allergy or bronchial asthma
* Renal failure - Children (patients less than 18 years of age)
* Pregnant women
* Breast feeding women
* Patients with inability to give informed consent

Where it's running

• Northwell Health
  Manhasset, New York, United States Recruiting

Study contacts

• Study coordinator: Betsy Moclair
• Email: bmoclair@northwell.edu
• Phone: 5162537753

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions

  A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.

  Recruiting Brigham and Women's Hospital · Boston, Massachusetts · NCT07883720

• Maintenance radiotherapy after standard glioblastoma treatment

  This study tests whether a single 2 Gy maintenance radiotherapy dose after standard treatment is safe and feasible for adults with newly diagnosed glioblastoma.

  Recruiting University of Minnesota · Minneapolis, Minnesota · NCT07831772

• BCB-276 CAR T therapy for DIPG in children and young adults

  This study tests BCB-276, a patient's own CAR T cells against DIPG, after standard radiation, to see if it is safe and can help extend survival.

  Recruiting at 3 sites Phase 2 BrainChild Bio, Inc · Los Angeles, California and 5 other locations · NCT07680439

• Temozolomide safety and effectiveness in adults with Grade III–IV glioma

  This study tests how safe and effective Amitzo temozolomide is in adults with Grade III or IV glioma in Iran, without a control group.

  Recruiting NanoAlvand · Tehran · NCT07675070

• Home-based vision training guided by brain imaging

  This study tests whether at‑home, image-guided visual training can improve visual field function for adults with stroke-related vision loss.

  Recruiting Georgetown University · Washington D.C., District of Columbia · NCT07635329

• Memantine and raloxifene to protect memory after brain radiation

  This study tests whether adding memantine and raloxifene to brain radiation can help adults preserve memory better than radiation alone.

  Recruiting Phase 2 The University of Texas Health Science Center at San Antonio · San Antonio, Texas · NCT07470606

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.